DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C1140680 | Malignant neoplasm of ovary | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0019360 | Herpes zoster disease | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C3714756 | Intellectual Disability | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0476089 | Endometrial Carcinoma | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0035934 | Rubinstein-Taybi Syndrome | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0015230 | Exanthema | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0600139 | Prostate carcinoma | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
C1136382 | Sclerocystic Ovaries | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
C0376358 | Malignant neoplasm of prostate | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
C1832661 | ANOPHTHALMIA AND PULMONARY HYPOPLASIA | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
C0009402 | Colorectal Carcinoma | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
C0032460 | Polycystic Ovary Syndrome | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
C0023794 | Lipoidosis | GDPD3 | 79153 | glycerophosphodiester phosphodiesterase domain containing 3 | Q7L5L3 |
C0006142 | Malignant neoplasm of breast | CYB5R4 | 51167 | cytochrome b5 reductase 4 | Q7L1T6 |
C0342276 | Maturity onset diabetes mellitus in young | CYB5R4 | 51167 | cytochrome b5 reductase 4 | Q7L1T6 |
C0011847 | Diabetes | CYB5R4 | 51167 | cytochrome b5 reductase 4 | Q7L1T6 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | CYB5R4 | 51167 | cytochrome b5 reductase 4 | Q7L1T6 |
C0085207 | Gestational Diabetes | CYB5R4 | 51167 | cytochrome b5 reductase 4 | Q7L1T6 |
C0271650 | Impaired glucose tolerance | CYB5R4 | 51167 | cytochrome b5 reductase 4 | Q7L1T6 |
C0011849 | Diabetes Mellitus | CYB5R4 | 51167 | cytochrome b5 reductase 4 | Q7L1T6 |
C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | CHST9 | 83539 | carbohydrate sulfotransferase 9 | Q7L1S5 |
C3463824 | MYELODYSPLASTIC SYNDROME | CHST9 | 83539 | carbohydrate sulfotransferase 9 | Q7L1S5 |
C0023449 | Acute lymphocytic leukemia | CHST9 | 83539 | carbohydrate sulfotransferase 9 | Q7L1S5 |
C0036341 | Schizophrenia | CHST9 | 83539 | carbohydrate sulfotransferase 9 | Q7L1S5 |
C0376545 | Hematologic Neoplasms | CHST9 | 83539 | carbohydrate sulfotransferase 9 | Q7L1S5 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024